It may therefore be speculated that the PPAR-α stimulatory component of lanifibranor, a balanced PPAR-α/δ/Υ agonist75, could preclude anti-neoplastic in GAN DIO-NASH-HCC mice. This evidence concerns the gene PPARA and hepatocellular carcinoma.